<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Acute Myeloid Leukemia: Developing Drugs and Biological Products for Treatment; Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Acute Myeloid Leukemia: Developing Drugs and Biological Products for Treatment; Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2022-10-18 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled "Acute Myeloid Leukemia: Developing Drugs and Biological Products for Treatment." This guidance is intended to assist sponsors in the clinical development of drugs and biological products for the treatment of acute myeloid leukemia (AML). This guidance addresses FDA's current thinking regarding the overall development program and clinical trial designs for the development of ...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2022-22618</p>
    <p><strong>Publication Date:</strong> 2022-10-18</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2022/10/18/2022-22618/acute-myeloid-leukemia-developing-drugs-and-biological-products-for-treatment-guidance-for-industry">https://www.federalregister.gov/documents/2022/10/18/2022-22618/acute-myeloid-leukemia-developing-drugs-and-biological-products-for-treatment-guidance-for-industry</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2022-22618</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
